Related Experiment Video

Updated: Oct 2, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

[Idiopathic membranous nephropathy in an elderly patient with type 2 diabetes mellitus]

O Costero1, C Díaz, F de Alvaro

  • 1Servicio de Nefrología Hospital La Paz Paseo de la Castellana, 261 28046 Madrid. costerof@jazzfree.com

Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|January 31, 2002
PubMed

Insights

An elderly patient with type 2 diabetes mellitus presented with nephrotic syndrome. Kidney biopsy revealed membranous nephropathy, unresponsive to steroid treatment, highlighting the need for considering glomerulonephritis beyond diabetic kidney disease.

Area of Science:

  • Nephrology
  • Diabetology
  • Pathology

Background:

  • Type 2 diabetes mellitus is a common cause of chronic kidney disease.
  • Nephrotic syndrome in diabetic patients often suggests underlying glomerular pathology.
  • Distinguishing diabetic glomerulosclerosis from other glomerulonephritides is crucial for appropriate management.

Observation:

  • An 85-year-old patient with type 2 diabetes mellitus presented with clinical and biochemical nephrotic syndrome.
  • Renal biopsy confirmed stage I-II membranous nephropathy.
  • The patient showed no signs of malignancy and did not respond to steroid therapy.

Findings:

  • Membranous nephropathy was diagnosed in an elderly diabetic patient with nephrotic syndrome.
  • The condition was refractory to standard steroid treatment.
  • This case underscores the importance of considering alternative diagnoses in diabetic nephropathy.

Implications:

  • Identifying non-diabetic glomerulonephritis is critical for guiding therapy and improving patient outcomes.
  • Kidney biopsy is essential for accurate diagnosis when diabetic glomerulosclerosis is suspected but clinical presentation is atypical.
  • Understanding pathogenic links between diabetes and other glomerular diseases can inform future research and treatment strategies.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...